Brilliant Blue G for Intraocular Injection 0 — Class III drug recall D-0607-2018
Terminated recall by Pine Pharmaceuticals, LLC, reported 2018-03-28, distributed in NY. Labeling: Label Mix-Up: Brilliant Blue G was labeled with an inaccurate auxiliary label which contained active
| Recall number | D-0607-2018 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Pine Pharmaceuticals, LLC, Tonawanda, NY, United States |
| Recall initiated | 2018-03-05 |
| Classified | 2018-03-26 |
| Reported by FDA | 2018-03-28 |
| Terminated | 2018-04-23 |
| Distributed | NY |
| Quantity | 136 units |
| Reason classes | labeling |
| NDC | 69194-0358-01 |
| Expiration dates | 2018-07-16 |
Product
Brilliant Blue G for Intraocular Injection 0.5mL vial 0.25 mg/mL Compounded by: Pine Pharmaceuticals 355 Riverwalk Pkwy Tonawanda, NY 14150. NDC 69194-0358-01
Reason for recall
Labeling: Label Mix-Up: Brilliant Blue G was labeled with an inaccurate auxiliary label which contained active/inactive ingredient information for incorrect product.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0607-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.